Jan 10, 2017 14:30 pm UTC| Business
SAN DIEGO, Jan. 10, 2017 -- Cytori Therapeutics, Inc. (NASDAQ:CYTX), as part of its corporate update at the Biotech Showcase, announced its intention to broaden its investigation of the ECCS-50 formulation of Cytori...
Milestone Certification Achieved for Eternity Healthcare’s Lenis® Device
Jan 10, 2017 14:30 pm UTC| Business
PHOENIX and VANCOUVER, B.C., Jan. 10, 2017 -- Eternity Healthcare Inc. (OTC:ETAH), announces first regulatory approval of its Lenis®, Needle-Free Injector. “CE Certification opens the door for regulatory approval in...
Jan 10, 2017 14:26 pm UTC| Business
Charlotte, N.C., Jan. 10, 2017 -- Capital Bank Financial Corp. (Nasdaq: CBF) today announced that it will release its fourth-quarter 2016 financial results on Thursday, January 26, 2017, and management will host a...
Norsk Hydro: Invitation - Hydro`s fourth quarter results 2016
Jan 10, 2017 14:16 pm UTC| Business
Hydro's fourth quarter results 2016 will be released at 07:00 CET (01:00 AM EST, 06:00 UK time), on Thursday February 9, 2016. The quarterly report and presentation slides will be available on www.hydro.com at the same...
Adherium appoints digital health pioneer to lead European business development
Jan 10, 2017 14:16 pm UTC| Business
Digital health veteran to join expanding global team MELBOURNE, Australia, Jan. 10, 2017 -- Adherium Limited (ASX:ADR), a global leader in digital health technologies that address sub-optimal medication use in chronic...
Key Tronic Announces Second Quarter Reporting Date
Jan 10, 2017 14:15 pm UTC| Business
SPOKANE VALLEY, Wash., Jan. 10, 2017 -- Key Tronic Corporation (Nasdaq:KTCC), announced today that it plans to report its results for the second quarter of fiscal 2017 after market close on January 31, 2017. Key...
PharmaCyte Biotech Discusses Upcoming Clinical Trial with Principal Investigator Dr. Manuel Hidalgo
Jan 10, 2017 14:10 pm UTC| Business
LAGUNA HILLS, Calif., Jan. 10, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell...